Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,114 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Niraparib plus abiraterone acetate with prednisone in patients with metastatic castration-resistant prostate cancer and homologous recombination repair gene alterations: second interim analysis of the randomized phase III MAGNITUDE trial.
Chi KN, Sandhu S, Smith MR, Attard G, Saad M, Olmos D, Castro E, Roubaud G, Pereira de Santana Gomes AJ, Small EJ, Rathkopf DE, Gurney H, Jung W, Mason GE, Dibaj S, Wu D, Diorio B, Urtishak K, Del Corral A, Francis P, Kim W, Efstathiou E. Chi KN, et al. Among authors: saad m. Ann Oncol. 2023 Sep;34(9):772-782. doi: 10.1016/j.annonc.2023.06.009. Epub 2023 Jul 1. Ann Oncol. 2023. PMID: 37399894 Free article. Clinical Trial.
Niraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer.
Chi KN, Rathkopf D, Smith MR, Efstathiou E, Attard G, Olmos D, Lee JY, Small EJ, Pereira de Santana Gomes AJ, Roubaud G, Saad M, Zurawski B, Sakalo V, Mason GE, Francis P, Wang G, Wu D, Diorio B, Lopez-Gitlitz A, Sandhu S; MAGNITUDE Principal Investigators. Chi KN, et al. Among authors: saad m. J Clin Oncol. 2023 Jun 20;41(18):3339-3351. doi: 10.1200/JCO.22.01649. Epub 2023 Mar 23. J Clin Oncol. 2023. PMID: 36952634 Free PMC article. Clinical Trial.
Clinical outcomes of abiraterone acetate and predictors of its treatment duration in metastatic castration-resistant prostate cancer: Real-world experience in the Southeast Asian cohort.
Lim J, Amantakul A, Shariff N, Lojanapiwat B, Alip A, Ong TA, Thevarajah S, Ahmayuddin F, Mathew A, Sriplakich S, Vuthiwong J, Chong FLT, Saad M. Lim J, et al. Among authors: saad m. Cancer Med. 2020 Jul;9(13):4613-4621. doi: 10.1002/cam4.3101. Epub 2020 May 6. Cancer Med. 2020. PMID: 32374087 Free PMC article.
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with prostate cancer.
Kanesvaran R, Castro E, Wong A, Fizazi K, Chua MLK, Zhu Y, Malhotra H, Miura Y, Lee JL, Chong FLT, Pu YS, Yen CC, Saad M, Lee HJ, Kitamura H, Prabhash K, Zou Q, Curigliano G, Poon E, Choo SP, Peters S, Lim E, Yoshino T, Pentheroudakis G. Kanesvaran R, et al. Among authors: saad m. ESMO Open. 2022 Aug;7(4):100518. doi: 10.1016/j.esmoop.2022.100518. Epub 2022 Jul 4. ESMO Open. 2022. PMID: 35797737 Free PMC article.
Prostate cancer management in Southeast Asian countries: a survey of clinical practice patterns.
Chiong E, Saad M, Hamid ARAH, Ong-Cornel AB, Lojanapiwat B, Pripatnanont C, Serrano D, Songco J, Sin LC, Hakim L, Chua MLK, Nguyen NP, Phuong PC, Patnaik RS, Umbas R, Kanesvaran R. Chiong E, et al. Among authors: saad m. Ther Adv Med Oncol. 2024 Jan 18;16:17588359231216582. doi: 10.1177/17588359231216582. eCollection 2024. Ther Adv Med Oncol. 2024. PMID: 38249332 Free PMC article.
Recent trend of androgen deprivation therapy in newly diagnosed prostate cancer patients: Comparing between high- and middle-income Asian countries.
Lim J, Onozawa M, Saad M, Ong TA; A-CaP (Asian Prostate Cancer) Study; J-CaP (Japan Prostate Cancer Study Group); M-CaP (Malaysia Prostate Cancer Study Group); Malek R, Akaza H. Lim J, et al. Among authors: saad m. Cancer Sci. 2021 Jun;112(6):2071-2080. doi: 10.1111/cas.14889. Epub 2021 May 3. Cancer Sci. 2021. PMID: 33738901 Free PMC article. Review.
2,114 results